TITLE

What's your call?

AUTHOR(S)
Madan, Vishal; Lear, John
PUB. DATE
April 2007
SOURCE
CMAJ: Canadian Medical Association Journal;4/24/2007, Vol. 176 Issue 9, p1275
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents a clinical report of a man diagnosed with pustular erythematous lesions. The disease was developed after a day he got minor scratches by accident. It was described a nonspecific hyperreactivity and diagnostic criteria for Behçet's disease. This disease is a multisystem inflammatory disorder which mainstay treatment are nonsteroidal anti-inflammatory agents, immunosuppressants and corticosteroids, although the choice of treatments is dictated by the symptoms.
ACCESSION #
25007900

 

Related Articles

  • AVANÇOS NO CONHECIMENTO DA DOENÇA DE STILL DO ADULTO. CABANELAS, Nuno; FERREIRA, Patrícia; ESTEVES, Maria Cristina; ROXO, Fausto // Acta Medica Portuguesa;2011, Vol. 24 Issue 1, p183 

    Introduction: Adult Still's Disease has systemic consequences, an inflammatory origin and unknown etiology. Knowledge about this disease is still limited, but some evolution has occurred in the last few years. Aims: Using a clinical case as example, the purpose of this paper is to review actual...

  • Classic disease modifying anti-rheumatic drugs (DMARDs) in combination with infliximab. The Finnish experience. Nordström, D. C.; Konttinen, L.; Korpela, M.; Tiippana-Kinnunen, T.; Eklund, K.; Forsberg, S.; Ilva, K.; Kaipiainen-Seppänen, O.; Malmi, T.; Ylä-Kerttula, T.; Honkanen, V. // Rheumatology International;Jun2006, Vol. 26 Issue 8, p741 

    To assess the performance of infliximab in a clinical setting, 364 rheumatoid arthritis (RA) patients from the National Register of Biological Treatment in Finland (ROB-FIN) were analysed. Corticosteroid usage and dose diminished ( p<0.05 and 0.001, respectively) in patients on infliximab, of...

  • Do injections ease shoulder pain? Williams, Alex // GP: General Practitioner;9/15/2003, p74 

    The reviewers found no evidence that intra-articular corticosteroid injections have any benefit. However, one small randomised, controlled trial found that forced manipulation and intra-articular cortico-steroid injection under anaesthesia reduced the number of people with disability from frozen...

  • Modelling the costs and effects of leflunomide in rheumatoid arthritis. Kobelt, G.; Lindgren, P.; Young, A. // European Journal of Health Economics;Sep2002, Vol. 3 Issue 3, p180 

    This study investigated the cost-effectiveness of leflunomide (LEF) compared to methotrexate (MTX) and sulfasalazine (SSZ) in the United Kingdom. A Markov model was constructed using health states defined by Health Assessment Questionnaire score. The model is based on a cohort of patients with...

  • The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment. Wang, Y.; Wang, V. M.; Chan, C.-C. // Eye;Feb2011, Vol. 25 Issue 2, p127 

    Although age-related macular degeneration (AMD) is not a classic inflammatory disease like uveitis, inflammation has been found to have an important role in disease pathogenesis and progression. Innate immunity and autoimmune components, such as complement factors, chemokines, cytokines,...

  • Medical Management of Uveitis - Current Trends. Babu, Kalpana; Mahendradas, Padmamalini // Indian Journal of Ophthalmology;Jun2013, Vol. 61 Issue 6, p277 

    Uveitis is a challenging disease to treat. Corticosteroids have been used in the treatment of uveitis for many years. Immunosuppressives are gaining momentum in recent years in the treatment of uveitis. In this article we present an overview of current treatment of uveitis and the major...

  • Hemophagocytic syndrome in adult-onset Still's disease (AOSD): A must for biologics?-Case report and brief review of the literature. Bürgi, Urs; Mendez, Adriana; Hasler, Paul; Hüllstrung, Hans // Rheumatology International;Oct2012, Vol. 32 Issue 10, p3269 

    A case of adult-onset Still's disease complicated by hemophagocytic lymphohistiocytosis is reported. Its management is being discussed on the background of the latest literature with special regard on the use of high-dose corticosteroids and immunosuppressive agents.

  • SYSTEMIC LUPUS ERYTHEMATOSUS — AN IMMUNOLOGICAL DISORDER: CLINICAL PRESENTATIONS AND THERAPEUTIC OPTIONS. AFZAL, N.; SHEHZAD, F.; RASHEED, S. // Biomedica;Sep2014, Vol. 30 Issue 3, p1 

    Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by production of numerous autoantibodies and damage to multiple organs and systems. SLE most often affects heart, joints, skin, lungs, blood vessels, liver, and kidneys. SLE is seen in young women of childbearing age (20...

  • Tocilizumab for the treatment of adult-onset Still's disease: results from a case series. Cipriani, Paola; Ruscitti, Piero; Carubbi, Francesco; Pantano, Ilenia; Liakouli, Vasiliki; Berardicurti, Onorina; Giacomelli, Roberto // Clinical Rheumatology;Jan2014, Vol. 33 Issue 1, p49 

    Adult-onset Still's disease (AOSD) is a chronic inflammatory disease of unknown etiology which commonly affects young adults. Treatment of AOSD patients includes nonsteroidal anti-inflammatory drugs, corticosteroids, and DMARDs. Interleukin (IL)-6 blockade is an attractive therapeutic option for...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics